22157.jpg
Global Interventional Oncology Devices Market Report 2023: Players Include Boston Scientific, Medtronic, Terumo, and Philips Volcano
March 30, 2023 10:18 ET | Research and Markets
Dublin, March 30, 2023 (GLOBE NEWSWIRE) -- The "Interventional Oncology Devices Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides...
Contrive Datum Insights_Logo.jpg
Core Biopsy Needles Market to Rise at 5.5% CAGR during Forecast Period 2023-2030, Data By Contrive Datum Insights
March 28, 2023 10:23 ET | Contrive Datum Insights Pvt Ltd
Farmington, March 28, 2023 (GLOBE NEWSWIRE) -- The Global Core Biopsy Needles Market Size Is Projected To Grow At A CAGR Of 5.5% During The Forecast Period 2022-2030. A biopsy is a surgical...
Elevar Logo for Common Use.png
Elevar Therapeutics to Present Clinically Supported Poster at AACR 2023 Demonstrating Rivoceranib as a Potent, and Most Selective, TKI for VEGFR-2
March 16, 2023 08:00 ET | Elevar Therapeutics
FORT LEE, N.J., March 16, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who...
Contrive Datum Insights_Logo.jpg
Computer Aided Diagnostics (CADx) Market Estimated to Grow at a CAGR of 13.3% from 2022 to 2030, Contrive Datum Insights
January 24, 2023 09:49 ET | Contrive Datum Insights Pvt Ltd
Farmington, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The global Computer Aided Diagnostics (CADx) Market size was valued at USD 5.62 Billion in 2022. It is expected to expand at a compound annual growth...
Global Flow Cytometry in Oncology Market
Flow Cytometry in Oncology and Immunology Global Market Report 2022: Innovation in Flow Cytometry Leading to Use of Next-Generation Flow Cytometers
November 29, 2022 04:03 ET | Research and Markets
Dublin, Nov. 29, 2022 (GLOBE NEWSWIRE) -- The "Flow Cytometry in Oncology and Immunology Market - A Global Market and Regional: Focus on Offering, Technology, End User, Type, Application, and...
interventional-oncology-market-size.jpg
The Worldwide Interventional Oncology Industry is Expected to Reach $2.9 Billion by 2028
November 24, 2022 08:08 ET | Research and Markets
Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The "Global Interventional Oncology Market Size, Share & Industry Trends Analysis Report By Cancer Type (Liver Cancer, Lung Cancer, Kidney Cancer,...
22157.jpg
Global Interventional Oncology Market Analysis Report 2022: A $2.11 Billion Market by 2026 - Forecasts to 2029
November 23, 2022 06:08 ET | Research and Markets
Dublin, Nov. 23, 2022 (GLOBE NEWSWIRE) -- The "Interventional Oncology Global Market - Forecast to 2026" report has been added to ResearchAndMarkets.com's offering. The Interventional Oncology...
researchdrivelogo.jpg
Global Liver Disease Treatment Market Anticipated to Garner $32,028.5 Million, Growing with 11.7% CAGR in the 2021–2028 Timeframe [240-Pages] | Wrap up by Research Dive
October 12, 2022 08:59 ET | Research Dive
New York, USA, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Research Dive has published a new report on the global liver disease treatment market. According to the report, the global market is projected to...
Persbericht Biocartis Group NV: Biocartis initieert commercialisatie in Europa van HepatoPredict (CE-IVD) test voor leverkankerpatiënten
October 10, 2022 01:00 ET | Biocartis NV
PERSBERICHT: 10 oktober 2022, 07:00 CEST Biocartis initieert commercialisatie in Europa van HepatoPredict (CE-IVD) test voor leverkankerpatiëntenHepatoPredict helpt patiënten met hepatocellulair...
Press news Biocartis Group NV: Biocartis Initiates Commercialization in Europe of HepatoPredict (CE-IVD) Test for Liver Cancer Patients
October 10, 2022 01:00 ET | Biocartis NV
PRESS RELEASE: 10 October 2022, 07:00 CEST Biocartis Initiates Commercialization in Europe of HepatoPredict (CE-IVD) Test for Liver Cancer PatientsHepatoPredict helps identify Hepatocellular...